Results 231 to 240 of about 912,975 (349)

Robust hepatitis C virus infection in vitro.

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2005
Jin Zhong   +9 more
semanticscholar   +1 more source

Genetic and transcriptional insights reveal hepatitis C virus as a driver of kidney cancer. [PDF]

open access: yesInfect Agent Cancer
Wang Q   +7 more
europepmc   +1 more source

A Phase 1, Randomized, Open‐Label, Parallel Group Study to Evaluate the Relative Bioavailability and Safety of Subcutaneous Bepirovirsen when Delivered from a Vial or Prefilled Syringe Fitted with a Safety Syringe Device in Healthy Adult Participants

open access: yesClinical Pharmacology in Drug Development, EarlyView.
Abstract Bepirovirsen, an antisense oligonucleotide in development for the treatment of chronic hepatitis B virus (HBV) infection, is administered from glass vials as a subcutaneous (SC) injection by healthcare professionals (HCPs). A ready‐to‐use prefilled syringe (PFS) assembled with a safety syringe device (SSD) has been developed to make ...
Amir S. Youssef   +15 more
wiley   +1 more source

Extrahepatic manifestations of chronic hepatitis C virus infection

open access: yesTherapeutic Advances in Infectious Disease, 2016
P. Cacoub   +5 more
semanticscholar   +1 more source

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis.

open access: green, 1990
Nobuyuki Kato   +6 more
openalex   +1 more source

Transmission of Hepatitis C Virus from Mothers to Infants [PDF]

open access: bronze, 1994
Hitoshi Ohto   +11 more
openalex   +1 more source

Association of Postpartum Inpatient Consultation Compared With Outpatient Referral With Hepatitis C Virus Treatment Completion. [PDF]

open access: yesO G Open
McCrary LM   +13 more
europepmc   +1 more source

Expression of mutant TIE2 p.L914F during mouse development causes embryonic lethality and defects in vascular remodeling

open access: yesDevelopmental Dynamics, EarlyView.
Abstract Background Sporadic venous malformation (VM) is associated with the hyperactivating p.L914F mutation in TIE2, a receptor tyrosine kinase essential for vascular development. This mutation is not found in hereditary VM, suggesting incompatibility with life when expressed during early vascular development.
Lindsay J. Bischoff   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy